MTVA MetaVia Inc.
Company Analysis
Latest News
🔴 MTVA is trading 6.3% down today with no clear catalyst identified
MTVA is trading 6.3% down at $1.47 in pre-market trading with no clear catalyst identified for the move. • The decline extends recent downside volatility...
🔴 MetaVia Inc. is trading 4.1% down today
MetaVia Inc. is trading at $1.53 (-4.06%) with no clear company-specific catalyst identified from available news coverage. • The stock’s recent weakness...
🔴 MetaVia Inc. is trading 5.6% down today amid post-Fed risk-off pressure and rising yields
MetaVia Inc. is trading 5.6% down at $1.61 as a post-Fed risk-off tone continues to weigh on speculative small-cap biotech names. • The stock experienced a...
🔴 MetaVia Inc. is trading 6.4% down today amid a broader post-Fed risk-off tone and market weakness
MetaVia Inc. is trading at $1.60 (-6.43%) in pre-market following a broader post-Fed risk-off tone that has pressured major indices and futures. • The...
🔴 MetaVia Inc. is trading 5.3% down today following broader market decline and Fed's hawkish stance; company announced upcoming investor forum
MetaVia Inc. is trading at $1.62 (5.3% down) in after-hours trading. The stock declined from a regular-session close of $1.71**, amidst a broader market...
🟢 MetaVia Inc. is trading 7.5% up today amid a tech-led market rebound and easing U.S.-Iran tensions
MetaVia Inc. is trading 7.5% up today at $1.87 amid a strong, tech-led market rebound and improved risk appetite. • Major indices are trending higher, with...
🔴 MetaVia Inc. makes sharp 10.2% drop
MTVA is trading at $1.80, down 10.2% versus the comparison close of $2.01 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 MetaVia Inc. is trading 5.5% down today as traders lock in profits after obesity pipeline rally
MetaVia Inc. is trading 5.5% down today at $1.90 as the stock retraces sharp gains driven by recent obesity and cardiometabolic pipeline headlines. • The...
🔴 MetaVia Inc. is trading 6.1% down today as early enthusiasm for obesity pipeline update fades
MetaVia Inc. is trading at $1.84 (6.1% down) as initial gains tied to its obesity and metabolic pipeline update faded during regular trading. • Investors were...
🟢 MetaVia Inc. (MTVA) shares rise 8.7% ahead of conference presentation
MetaVia Inc. is trading at $2.13 (up 8.7%) in pre-market action as investors anticipate a company update on its key drug pipeline later today. • The company...
🔴 MetaVia Inc. is trading 5% down today as dilution fears persist following reverse split approval
MetaVia Inc. is trading 5% down at $1.79 as traders react to last week’s shareholder approval of a reverse stock split and an expanded equity incentive...
🔴 MetaVia Inc. is trading 18.5% down today on dilution fears after reverse split and equity plan approval
MetaVia Inc. is trading 18.5% down at $1.81 after shareholders approved a reverse stock split and an expanded equity incentive plan on June 8. • The approval...
🔴 MetaVia Inc. is trading 20.7% down today after reverse split and equity plan approval
MetaVia Inc. is trading 20.7% down at $1.76 in pre-market, extending a sharp slide after stockholders approved a reverse stock split and an expanded equity...
🔴 MetaVia Inc. is trading 12.6% down today after stockholders approved a reverse stock split and equity plan expansion
MetaVia Inc. is trading at $1.94 (-12.61%) in after-hours trading after stockholders approved a reverse stock split and an equity plan expansion during the...
MetaVia Stockholders Approve Reverse Stock Split and Equity Plan Expansion
At its 2026 Annual Meeting on June 8, 2026, MetaVia Inc. (MTVA) stockholders voted to approve all proposals, including a reverse stock split of the company's...
MetaVia Shareholders Approve Reverse Stock Split of Up to 1-for-22
MetaVia Inc. (MTVA) shareholders approved all five proposals during the June 8, 2026, annual meeting. The board gained authority to execute a reverse stock...
MetaVia Reports Positive Phase 1 Data Showing 9.1% Weight Loss for Obesity Drug DA-1726
MetaVia Inc. announced new late-breaking data from its obesity and metabolic disease portfolio presented at the American Diabetes Association’s (ADA) 2026...
🔴 MetaVia Inc. is trading 17.5% down today as traders unwind momentum from ADA conference rally
MetaVia Inc. is trading 17.5% down at $2.12 today as traders unwind momentum following a sharp pullback from last week’s ADA conference rally. • Investors are...
🔴 MetaVia Inc. is trading 13.2% down today as traders unwind momentum following ADA obesity data
MetaVia Inc. is trading 13.2% down at $2.23 in pre-market action as investors digest detailed data from the company's American Diabetes Association (ADA) 2026...
🔴 MetaVia Inc. is trading 6% down today after clinical data on its obesity drug candidate
MetaVia Inc. is trading approximately 6% down at $2.42 in after-hours trading as investors digest clinical data for its dual GLP-1/glucagon candidate,...